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Mechanical strain is an important determinant of bone mass and architecture, and the aim
of this investigation was to further understand the role of the cell–cell signaling molecules,
IL-1β, TNF-α, and IL-6 in the mechanobiology of bone. Mouse calvarial osteoblasts in mono-
layer culture were subjected to a cyclic out-of-plane deformation of 0.69% for 6 s, every 90 s
for 2–48 h, and the levels of each cytokine plus their downstream targets RANKL and OPG
measured in culture supernatants by ELISAs. Mouse osteoblasts constitutively synthesized
IL-1β, TNF-α, and IL-6, the production of which was significantly up-regulated in all three by
cyclic mechanical strain. RANKL and OPG were also constitutively synthesized; mechan-
ical deformation however, resulted in a down-regulation of RANKL and an up-regulation
OPG synthesis. We next tested whether the immunoreactive RANKL and OPG were bio-
logically active in an isolated osteoclast resorption pit assay – this showed that culture
supernatants from mechanically deformed cells significantly inhibited osteoclast-mediated
resorptive activity across the 48 h time-course.These findings are counterintuitive, because
IL-1β, TNF-α, and IL-6 have well-established reputations as bone resorptive agents. Never-
theless, they are pleiotropic molecules with multiple biological activities, underlining the
complexity of the biological response of osteoblasts to mechanical deformation, and the
need to understand cell–cell signaling in terms of cytokine networks. It is also important to
recognize that osteoblasts cultured in vitro are deprived of the mechanical stimuli to which
they are exposed in vivo – in other words, the cells are in a physiological default state that
in the intact skeleton leads to decreased bone strains below the critical threshold required
to maintain normal bone structure.
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INTRODUCTION
Mechanical stimuli play an important role in the growth, struc-
ture, and maintenance of skeletal tissues. It has been estimated
that environmental factors such as physical activity and nutri-
tion account for 20–40% of individual variation in bone mass,
the remaining 60–80% being determined by genetic factors (1,
2). Mechanical stimuli may be growth-generated as in embryonic
tissues with differential growth rates (3), the result of functional
movement as in synovial joints (4, 5), the consequence of physi-
cal activity (6), or by the activation of orthodontic appliances. In
contrast, prolonged bed rest or weightlessness leads to bone loss
and osteopenia (7, 8).
In the adult skeleton, during normal physiological turnover
there is a balance between the amount of bone resorbed by
osteoclasts and that formed by osteoblasts to maintain a con-
stant bone mass (9). Bone resorption and bone formation are
therefore said to be coupled, a process of renewing the skeleton
while maintaining its structural integrity, embodied in the A-R-F
(activation-resorption-formation) sequence of the bone remodel-
ing cycle. Bone remodeling is orchestrated by cells of the osteoblast
lineage and involves a complex network of cell–cell signaling
mediated by systemic osteotropic hormones, locally produced
cytokines, growth factors, and the mechanical environment of
the cells (10–13). One of the most significant developments in
connective tissue biology during the 1980s was the finding that
cytokines such as interleukin-1 (IL-1), tumor necrosis factor
(TNF), and IL-6, originally identified as immunoregulatory mole-
cules, could also act as regulators of pathophysiological resorption
(14–17) and were produced by many different cell types including
osteoblasts (18).
Another key advance was the observation that osteoclast for-
mation and function in vitro was dependent upon the presence
of stromal cells/osteoblasts, which suggested that soluble factor(s)
were involved in osteoblast–osteoclast signaling (19). This led to
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the discovery of OPG (osteoprotegerin) and RANKL (receptor
activator of nuclear factor κB ligand), two cytokines synthesized by
osteoblasts (20–24), and constituents of a ligand–receptor system
known as the RANK/RANKL/OPG triad that directly regulates
the final steps of the bone resorptive cascade. RANKL which
exists in both membrane-bound and soluble forms stimulates
the differentiation and function of osteoclasts, an effect medi-
ated by RANK, a member of the TNF receptor family expressed
primarily on cells of the monocyte/macrophage lineage, includ-
ing osteoclasts and their precursor cells (25). OPG is a secreted
protein that inhibits osteoclastogenesis by acting as a decoy recep-
tor, binding to and neutralizing both cell-bound and soluble(s)
RANKL.
Following the initial mechanotransduction event at the cell
membrane, mechanical stimuli appear to influence bone remod-
eling by their ability to regulate the synthesis and/or action of
cytokines. Since remodeling occurs at distinct sites throughout
the skeleton, osteoblast cytokines are ideally placed to regulate or
modify the action of other cell types in bone, although the interac-
tions are complex and poorly understood. Using mouse calvarial
osteoblasts as our model, the aim of this study was to determine
the effect of cyclic mechanical strain on the synthesis and biolog-
ical activity of the pleiotropic cytokines IL-1β, TNF-α, IL-6, and
their downstream targets RANKL and OPG.
MATERIALS AND METHODS
PREPARATION OF MOUSE OSTEOBLASTS
Calvarial osteoblasts were prepared and characterized by a mod-
ification of the method previously described by Heath et al.
(26). Neonatal mouse calvaria from BALB/C mice were dissected
free from adherent soft tissue, washed in Ca2± and Mg2±free
Tyrode’s solution (10 min) and sequentially digested with 1 mg/ml
trypsin (for 20 and 40 min). Cells from these digests were dis-
carded; the bones were washed in phosphate buffered saline
(PBS) and cut into pieces for a third trypsin digest (20 min).
The cells released from this digest were washed in PBS, cen-
trifuged at 1000 rpm for 5 min and the pelleted cells resuspended
in 1:1 F12/Dulbecco’s modification of Eagle’s medium (DMEM)
supplemented with 20% fetal calf serum (GIBCO, Invitrogen,
Carlsbad, CA, USA), 100 units/ml penicillin, and 100µg/ml strep-
tomycin, then seeded into 75-cm flasks and grown to conflu-
ence at 37°C in a humidified atmosphere of 5% CO2/95% air.
The cells were identified as osteoblasts by morphological crite-
ria and the fact that more than 95% stained strongly for alkaline
phosphatase (ALP).
APPLICATION OF MECHANICAL DEFORMATION TO MOUSE
OSTEOBLASTS
After the cells had reached confluence (20–25 days), adherent cells
were detached with trypsin-EDTA (0.25%; Sigma), resuspended
in F12/DMEM with 10% fetal calf serum (Gibco), 100 units/ml
penicillin and 100µg/ml streptomycin and plated at an initial cell
density of 106 cells/dish into 35 mm Petriperm dishes (In vitro
Systems & Services GmbH, Germany) with flexible bases. Vacuum
pressure was used to displace the substrate – maximal deflection
2 mm, according to the method of Banes et al. (27) and a cyclic
strain applied to the cells for 6 s (0.166 Hz), every 90 s for 2–48 h as
described previously (28). The maximal strain applied to the cells
was calculated according to the formula:
Arc = 1
2
√
d2 + 16 b2 + d
2
8b
1n
(
4b +
√
d2 + 16 b2
d
)
d = diameter (33 mm); b=maximum deflection (2 mm);
Arc= 33.23 mm
max strain = Arc − d
d
100 = 0.69%.
Each dish contained 4 ml of F12/DMEM medium; 500µl was
sampled at each time point and 500µl fresh medium added.
Because the deformation is out-of-plane, the level of strain expe-
rienced by the cells will be greatest at the center and least at the
perimeter of the substrate and roughly half that programed into
the computer. The overall level of deformation is therefore compa-
rable with strain levels recorded at the surface of diaphyseal bone
in vivo (1–3× 106 microstrain) depending on location following
dynamic loading (29, 30).
CULTURE MEDIA PROTEOMICS
Media samples were supplemented with 1 mg/ml protease
inhibitor cocktail (Sigma-Aldrich P1860, St. Louis, MO, USA),
stored at −70°C and assayed 2 days later for IL-1β, TNF-α, IL-6,
OPG, and soluble sRANKL protein by enzyme-linked immunosor-
bent assays (ELISAs; R & D Systems, Minneapolis, MN, USA).
Absorbance was measured at 450 nm according to the manufac-
turer’s instructions.
OSTEOCLAST RESORPTION PIT ASSAY
The osteoclast resorption assay is based on the ability of isolated
osteoclasts to resorb cortical bone, dentine, or ivory slices in vitro
(31). Ivory was chosen as the substrate being free of vascular chan-
nels and pre-existing resorbing surfaces and osteoclasts produce
resorption pits in its smooth surface greatly facilitating quantifi-
cation. Ivory slices (250µm in thickness) were cut with a Micro
Slice 2 machine (Metals Research, Cambridge, England) at low
speed from a 1 cm diameter rod. Osteoclasts were obtained from
the femurs of 2–3-day-old BALB/C mice and allowed to settle on
the slices for 20 min at 37°C as described previously (32). The sub-
strate was then washed free of non-adherent cells, and the slices
incubated for 24 h in a humidified atmosphere of 5% CO2/95%
air at 37°C in 500µl of conditioned medium plus 500µl of fresh
DMEM supplemented with 5% fetal calf serum, 100 units/ml peni-
cillin, and 100µg/ml streptomycin in 1.5 cm multiwall plates. At
the completion of the culture period the cells were removed, the
ivory slices stained with trypan blue and resorption quantified by
measuring the surface area of the resorption lacunae by image
analysis (Stereoscopy Microscope model SKD/SKO/KTD, Arhe,
Holland). A single experiment consisted of eight ivory slices bear-
ing the cells from one mouse, with four slices for each control and
test variable.
STATISTICAL ANALYSIS
Data are expressed as mean± standard error of the mean (SEM).
Differences between control and experimental cultures were deter-
mined by the Student’s t -test (two tailed) using GraphPad Prism
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4 software (GraphPad Software Inc., San Diego, CA, USA) and the
level of significance set at P < 0.05.
RESULTS
EFFECTS OF CYCLIC MECHANICAL STRAIN ON CYTOKINE PRODUCTION
Mouse calvarial osteoblasts in monolayer culture constitutively
synthesized IL-1β, TNF-α, and IL-6 over the 48 h time-course
of the experiments; for IL-1β and TNF-α the levels were 103
pg/ml and for IL-6, 2–3× 103 pg/ml (Figure 1). Cyclic tensile
strain significantly up-regulated IL-1β and TNF-α synthesis two-
to threefold from 2 to 24 h, returning to control levels by 48 h
(Figure 1). In the case of IL-6 the increments were smaller (one-
to twofold), but of greater magnitude (4–8× 103 pg/ml), and were
sustained over the entire 48 h time-course (Figure 2).
EFFECTS OF CYCLIC STRAIN ON sRANKL AND OPG
Cultured mouse osteoblasts constitutively synthesized sRANKL
and OPG. From 2 to 24 h there was a significant reduction in the
level of sRANKL of approximately one- to twofold in mechani-
cally deformed cultures; from 24 to 48 h, however, immunoreactive
sRANKL returned to control levels (Figure 3). In contrast, OPG
levels were not significantly different over the first 24 h, but from
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FIGURE 1 | IL-1β andTNF-α production by mouse calvarial osteoblasts.
Osteoblasts in monolayer culture were subjected to a cyclic tensile strain
(6 s every 90 s) for 2–48 h and the culture media assayed for IL-1β and TNF-α
by ELISAs. Results are expressed as mean±SEM for 10 cultures.
***Experimental significantly greater than control. P <0.001.
24 to 48 h had increased by approximately 50% in culture media
from mechanically deformed cells (Figure 3).
INHIBITION OF OSTEOCLAST RESORPTION
In view of the well-established ability of IL-1β, TNF-α, and IL-6 to
stimulate bone resorption in vitro, and the importance of OPG and
RANKL in regulating the terminal pathway of the bone resorptive
cascade, we next tested the biological activity of the RANKL/OPG
ratio in the culture media using an isolated osteoclast resorption
pit assay. Figure 4 shows the contrary to expectation there was
a significant inhibition of osteoclast resorption by culture media
from mechanically strained cultures over the entire 2–48 h time
scale.
DISCUSSION
Rubin et al. (33) have shown that tensile mechanical strain (2%
at 10 cycles/min) applied to mouse bone marrow stromal cells
in vitro, decreased RANKL mRNA levels by 60%. Kusumi et al. (34)
have similarly reported a decrease in RANKL mRNA expression
and sRANKL release from human osteoblasts following 7% cyclic
tensile strain; they also found that mechanical strain increased
OPG synthesis. The present study builds on these findings, provid-
ing evidence for an upstream mechanism, and shows that contrary
to what one might have expected, mechanical stress up-regulated
the synthesis of IL-1β, TNF-α, and IL-6, three cytokines known to
be potent stimulators of bone resorption in vitro (14–17).
IL-1β, TNF-α, and IL-6 have also been shown to stimulate
osteoclast differentiation and bone resorption in a synergistic
manner (35), and perhaps unexpectedly, to increase the produc-
tion of both RANKL and OPG in the human osteosarcoma cell
line MG-63 (36–38), although the dominant outcome was a net
increase in RANKL activity (39, 40). We were therefore surprised to
find that while intermittent tensile strain up-regulated IL-1β, TNF-
α, and IL-6 synthesis, OPG production increased and sRANKL
decreased, and when tested in an osteoclast resorption assay, cul-
ture supernatants from mechanically deformed cells were found
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FIGURE 2 | IL-6 production by mouse calvarial osteoblasts. Osteoblasts
in monolayer culture were subjected to a cyclic tensile strain (6 s every 90 s)
for 2–48 h and the culture media assayed for IL-6 by an ELISA. Results are
mean±SEM for 10 cultures. ***Experimental significantly greater than
control. P < 0.001.
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FIGURE 3 | RANKL and OPG production by mouse calvarial
osteoblasts. Osteoblasts in monolayer culture were subjected to a cyclic
tensile strain (6 s every 90 s) for 2–48 h and the culture media assayed for
RANKL and OPG by ELISAs. Results are expressed as mean±SEM for 10
cultures. ***Experimental significantly different from control. P < 0.001.
to be inhibitory. This highlights the importance of bioassays. The
bone literature contains a good deal of information about gene
expression in normal and transformed cell lines, rather less about
whether the expressed genes of interest are translated into protein,
and if they are, whether the proteins are biologically active – in
other words, real functional molecules.
We have previously shown that cyclic mechanical strain in the
same model system inhibits IL-10 and stimulates IL-12 production
by mouse calvarial osteoblasts (28), two cytokines with the ability
to inhibit bone resorption. IL-10 selectively blocks osteoclasto-
genesis by inhibiting the differentiation of osteoclast progenitors
into preosteoclasts (41, 42), while IL-12 inhibits RANKL-induced
osteoclast formation in mouse bone marrow cell cultures, an effect
mediated by IFN-γ (43, 44). IL-10 also suppresses osteoblast differ-
entiation in mouse bone marrow cultures by inhibition of TGF-β1
production (45, 46).
These data underline the complexity of the biological response
of osteoblasts to mechanical deformation and the potential disad-
vantage of investigating a relatively small number of cytokines at
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FIGURE 4 | Effect of conditioned media from osteoblast cultures on the
surface area of mouse osteoclast resorption lacunae. Osteoclasts were
obtained from the femurs of 2–3-day-old BALB/C mice and allowed to settle
on ivory slices for 20 min at 37°C. The substrate was washed free of
non-adherent cells and the slices incubated for 24 h in 500µL of
conditioned medium plus 500µl fresh DMEM; resorption was quantified by
measuring the surface area of the resorption lacunae by image analysis. The
values represent the means±SEM from four slices at each time point.
***Experimental significantly less than control. P <0.001.
any one time. The fusion of real-time RT-PCR with microarray
technology, which enables a large panel of genes to be screened
at the same time under identical experimental conditions using
relatively small quantities of RNA, provides an opportunity to
significantly expand our knowledge of the number of mechanore-
sponsive genes expressed by bone cells. This has been used recently
for periodontal ligament cells in an attempt to understand cell–cell
signaling in terms of cytokine networks, and how these regulate
complex biological processes such as tooth movement (47, 48).
The downside is that more genomic data increases the difficulty
of establishing a coherent sequence of events at the protein level.
This brings us to the significance of the present findings in the
context of intact bone. Mechanical strain is an important deter-
minant of bone mass and architecture, and the introduction of
in vivo models in which carefully controlled external loads could
be applied to bone, led to important advances in understanding
the strain-dependent adaptation of bone to altered function (49–
51). These showed that increased bone strains above a certain
critical threshold resulted in bone formation, while reductions in
strain magnitude resulted in bone loss and osteopenia. In the jaws,
for example, masticatory hypofunction resulting from reduced
occlusal loading leads to a reduction in alveolar bone mass and
bone mineral density (52–55). Stress-shielding and disuse atrophy
resulting from the implantation of rigid metallic devices into bone,
is also a well-recognized complication of total hip arthroplasty and
fracture fixation in orthopedic surgery (56–58).
To describe this tissue-level regulatory negative-feedback
mechanism and add some clarity to the relationship between form
and function in bone, the principle of a “mechanostat” for regu-
lating bone mass was revived by Frost (59); the basic idea being
that for each bone in the skeleton, there is a functional or mechan-
ically adapted state within the boundaries of which normal bone
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mass is maintained. Osteoblasts cultured in vitro are deprived of
the mechanical stimuli to which they would normally be exposed
in vivo – in other words, the cells are in a physiological default
state that in the intact skeleton leads to a decrease in bone strains
below the critical threshold required for the maintenance of nor-
mal osseous architecture. The result is a localized negative skeletal
balance or osteopenia and the reason why in vitro models are ideal
for investigating bone resorption – the osteopenia is not perma-
nent, however, and can be reversed by the restoration of normal
functional loading.
The use of neonatal mouse calvaria as a source of primary cells
of the osteoblast lineage as an alternative to transformed cell lines
in bone biology is well-established. However, phenotypic differ-
ences exist between individual bones of the skeleton depending on
their anatomical location, and calvarial and limb bones do not
demonstrate the same responses to mechanical loading. Rawl-
inson et al. (60) recorded normal functional strains as low as
30 microstrain (µε) on rat parietal bone and found that unlike
tibial osteoblasts (derived from lateral plate mesoderm), calvar-
ial osteoblasts (of neural crest cell origin) did not show the same
early responses to dynamic mechanical strain. Direct strain mea-
surements in a human volunteer further showed that in the skull,
the highest strains recorded (200µε) were 10-fold lower than for
the tibia (61), levels that in the rest of the skeleton would lead to
profound bone loss.
Differences between neural crest and mesodermal bone in the
concentration of growth factors (62, 63), heterogeneity of the
enzymes produced by their osteoclasts (64, 65), patterns of expres-
sion of bone morphogenetic proteins (66) and the abundance of
several matrix proteins, notably collagen in calvarial bone (67)
have been reported. However, none provide an adequate answer
to the question: what makes calvarial bone resistant to levels of
mechanical strain that in the rest of the skeleton would lead to
profound bone loss? It cannot be because calvarial bone is derived
from the neural crest – the bones of the jaws are also of neural crest
cell origin and do not show the same resistance to reduced mechan-
ical loading. The well-characterized primary human calvarial and
femoral osteoblasts now available from commercial sources pro-
vides an opportunity to further investigate these aspects of the
mechanobiology of bone, but whether in vitro models are able to
provide the answer remains to be seen.
In conclusion, the findings of this investigation are counterintu-
itive because IL-1β, TNF-α, and IL-6 have well-established reputa-
tions as bone resorptive agents. Nevertheless, they are pleiotropic
molecules with multiple biological activities in addition to the
stimulation of resorption, underlining the complexity of the bio-
logical response of osteoblasts to mechanical deformation, and the
need to understand cell–cell signaling in terms of cytokine net-
works. It is also important to recognize that osteoblasts cultured
in vitro are in a physiological default state that in the skeleton
leads to decreased bone strains and osteopenia; this suggests that
the application of mechanical strain to osteoblasts in vitro results
in an osteogenic stimulus by restoring the metabolic activity of the
cells to levels approaching that produced by functional osteoblasts
in vivo.
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